{"changes":[],"country":"DE","description":"Akribion develops the G-dase E RNA-guided nuclease for programmable cell depletion in precision oncology. It targets clinicians treating HPV-induced head-and-neck cancers initially, with broader oncology potential. Differentiator: single-nucleotide specificity and rapid retargeting via gRNA exchange.","domain":"akribion-therapeutics.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":49.7242,"lng":8.5915,"location":"Zwingenberg, Germany","name":"Akribion Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":8640000,"currency":"EUR","date":"2025-02-15","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"akribion-therapeutics-com","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"akribion-therapeutics.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://akribion-therapeutics.com"},{"fact":"description","publisher":"akribion-therapeutics.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://akribion-therapeutics.com"}],"stage":"seed","techStack":["PHP 8.2.31","WordPress 6.9.4","Apache HTTP Server 2.4.67","Magnific Popup 8.45.1","UNIX","MySQL","apache 2.4.67","jquery 3.7.1"],"totalRaisedUsd":8640000,"updatedAt":"2026-05-02"}